Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRENE.L Regulatory News (RENE)

  • There is currently no data for RENE

Shares notification

31 Jan 2007 09:37

ReNeuron Group plc31 January 2007 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer RENEURON GROUP PLCof existing shares to which voting rights are attached 2. Reason for the notification (please tick the appropriate box or boxes)An acquisition or disposal of voting rights X An acquisition or disposal of financial instruments which may result in theacquisition of shares already issued to which rioting rights are attached An event changing the breakdown of voting rights 3. Full name of person(s) subject to the SAAD INVESTMENTS COMPANY LIMITED notification obligation4. Full name of shareholder(s) (if different from 3.) Vidacos Nominees Ltd (Citigroup Global AWAL)5. Date of the transaction and date on which the Not specified. threshold is crossed or reached6. Date on which issuer notified 30 January 2007 A: Voting rights attached to sharesClass/type Situation Resulting situation after the triggering transaction vi of shares previous to the Triggering if possible transactionusing the ISIN Number of Number Number of Number of voting rights % of voting rightsCODE Shares shares ix of Voting Rights Direct Direct Indirect Direct Indirect Ordinary Shares Not Not 18,950,000 18,950,000 0 15.988% 0 specified specified B: Financial InstrumentsResulting situation after the triggering transactionType of financial Expiration Exercise/Conversion Number of voting rights % of voting date Period/Date that may be acquired if rightsinstrument the instrument is - exercised/converted N/A - - - - Total (A+B)Number of voting rights % of voting rights 18,950,000 15.988% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectivelyheld, if applicable None specified. Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A12. Date on which proxy holder will cease to hold voting N/Arights: 13. Additional information: Recent acquisition. 14. Contact name: Michael Hunt, CEO15. Contact telephone number: 01483 302560 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Mar 20207:00 amRNSBlock Listing Review and Total Voting Rights
24th Feb 20207:00 amRNSPositive long-term data in retinal clinical trial
17th Feb 20207:00 amRNSPositive Phase 2a stroke clinical data published
12th Feb 20207:02 amRNSNotification of Major Holdings
12th Feb 20207:01 amRNSNotification of Major Holdings
12th Feb 20207:00 amRNSNotification of Major Holdings
7th Feb 20201:15 pmRNSNotification of Major Holdings
6th Feb 20209:51 amRNSNotification of Major Holdings
2nd Jan 20207:00 amRNSTotal Voting Rights
18th Dec 201912:10 pmRNSNotification of Major Holdings
16th Dec 20193:00 pmRNSNOTIFICATION OF MAJOR HOLDINGS
6th Dec 20197:00 amRNSInterim Results
18th Nov 20197:00 amRNSNotification of Interim Results
23rd Oct 20197:00 amRNSReNeuron's lead cell line shows further potential
17th Oct 20195:36 pmRNSNotification of Major Holdings
17th Oct 20193:21 pmRNSNotification of Major Holdings
14th Oct 20197:00 amRNSPositive clinical data presented at AAO meeting
2nd Oct 20194:40 pmRNSSecond Price Monitoring Extn
2nd Oct 20194:35 pmRNSPrice Monitoring Extension
2nd Oct 20197:00 amRNSClinical Update and Conference Presentations
12th Sep 201911:21 amRNSResult of AGM
10th Sep 20197:00 amRNSAGM Trading Update
2nd Sep 20197:00 amRNSBlock Listing Review and TVR
21st Aug 20197:00 amRNSAppointments to Scientific Advisory Board
14th Aug 20197:00 amRNSGrant-funded collaboration with exosome platform
2nd Aug 20194:00 pmRNSPosting of Annual Report and Notice of AGM
2nd Aug 20191:12 pmRNSNotification of Major Holdings
1st Aug 201911:50 amRNSTotal Voting Rights
17th Jul 20197:00 amRNSDirector/PDMR Interest in Shares & Share Options
16th Jul 20197:00 amRNSKey patent grants expand exosome IP portfolio
12th Jul 20197:00 amRNSSenior business development appointment
11th Jul 20197:00 amRNSPreliminary Results
8th Jul 20194:30 pmRNSNotification of Major Holdings
1st Jul 201911:00 amRNSPrice Monitoring Extension
1st Jul 20197:00 amRNSTotal Voting Rights
18th Jun 20194:01 pmRNSNotification of Major Holdings
18th Jun 20197:00 amRNSWebcast of Preliminary Results
14th Jun 201911:09 amRNSReNeuron wins Breakthrough of the Year Award
3rd Jun 20197:00 amRNSTotal Voting Rights
31st May 20197:00 amRNSJefferies 2019 Global Healthcare Conference
9th May 20195:05 pmRNSExercise of options, PDMR dealing and TVR
8th May 20197:00 amRNSYear-end update and results notification
2nd May 20193:43 pmRNSTotal Voting Rights
26th Apr 20194:40 pmRNSSecond Price Monitoring Extn
26th Apr 20194:35 pmRNSPrice Monitoring Extension
26th Apr 20197:00 amRNSClinical update and conference presentation
18th Apr 20193:40 pmRNSShare Purchases by Directors
12th Apr 20192:36 pmRNSExercise of Share Options and TVR
11th Apr 20194:31 pmRNSShare Purchases by Directors
10th Apr 20192:37 pmRNSDirector/PDMR Shares and Share Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.